Correlation Between Cannara Biotech and BC Bud

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cannara Biotech and BC Bud at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannara Biotech and BC Bud into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cannara Biotech and The BC Bud, you can compare the effects of market volatilities on Cannara Biotech and BC Bud and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannara Biotech with a short position of BC Bud. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannara Biotech and BC Bud.

Diversification Opportunities for Cannara Biotech and BC Bud

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cannara and BCBCF is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Cannara Biotech and The BC Bud in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BC Bud and Cannara Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannara Biotech are associated (or correlated) with BC Bud. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BC Bud has no effect on the direction of Cannara Biotech i.e., Cannara Biotech and BC Bud go up and down completely randomly.

Pair Corralation between Cannara Biotech and BC Bud

Assuming the 90 days horizon Cannara Biotech is expected to under-perform the BC Bud. But the otc stock apears to be less risky and, when comparing its historical volatility, Cannara Biotech is 5.21 times less risky than BC Bud. The otc stock trades about -0.01 of its potential returns per unit of risk. The The BC Bud is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  6.41  in The BC Bud on August 25, 2024 and sell it today you would lose (1.86) from holding The BC Bud or give up 29.02% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Cannara Biotech  vs.  The BC Bud

 Performance 
       Timeline  
Cannara Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cannara Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's technical and fundamental indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
BC Bud 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in The BC Bud are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental indicators, BC Bud reported solid returns over the last few months and may actually be approaching a breakup point.

Cannara Biotech and BC Bud Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cannara Biotech and BC Bud

The main advantage of trading using opposite Cannara Biotech and BC Bud positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannara Biotech position performs unexpectedly, BC Bud can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BC Bud will offset losses from the drop in BC Bud's long position.
The idea behind Cannara Biotech and The BC Bud pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities